It is worth considering the sale by Dexus last week of 44 Market St for a 17.2% discount.
Some commentators have suggested the stickiness of NTAs has been due to lack of sales to evidence a yield-based fall in values.
This sale seems to be around the level of some expectations for falls. It will be interesting to see if this now colours 30 June 2023 valuations.
- Forums
- ASX - By Stock
- COF
- Sales evidence
Sales evidence
Featured News
Add COF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
0.005(0.43%) |
Mkt cap ! $695.8M |
Open | High | Low | Value | Volume |
$1.16 | $1.18 | $1.16 | $479.4K | 411.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 148080 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 6944 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 32438 | 1.160 |
4 | 17101 | 1.155 |
14 | 163151 | 1.150 |
8 | 18657 | 1.140 |
1 | 8849 | 1.130 |
Price($) | Vol. | No. |
---|---|---|
1.185 | 16000 | 1 |
1.200 | 73233 | 5 |
1.220 | 24590 | 1 |
1.245 | 20920 | 1 |
1.250 | 2295 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
COF (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online